G. K. Haines

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

R. Sebra, M. Galsky, T. Dorff, 2023, Nature Medicine.

Dendritic Cell Activation Limit RIPK1- and MyD88-Mediated Caspase-8 Acts as a Molecular Rheostat To

J. Hutcheson, C. Mohan, H. Perlman, 2014 .

This information is current as Dendritic Cell Activation Limit RIPK 1-and MyD 88-Mediated Caspase-8 Acts as a Molecular Rheostat To Stehlik and

J. Hutcheson, C. Mohan, H. Perlman, 2014 .